Join the club for FREE to access the whole archive and other member benefits.

Novartis

Global medicines company for developing and producing drugs.

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.

Visit website: https://www.novartis.com/

 novartis

 novartis

 Novartis

 Novartis

Details last updated 25-Dec-2019

Novartis News

Novartis and Generate:Biomedicines forge $1B AI drug discovery deal

Novartis and Generate:Biomedicines forge $1B AI drug discovery deal

Genetic Engineering & Biotechnology News (GEN) - 24-Sep-2024

AI and biotech unite for next-gen protein drugs

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

pharmaphorum - 08-Jan-2024

Their AlphaFold engine models proteins could lead to faster and more effective treatments

Isomorphic labs teams up with pharma giants for AI-driven drug discovery

Isomorphic labs teams up with pharma giants for AI-driven drug discovery

TechCrunch - 07-Jan-2024

Eli Lilly and Novartis invest in cutting-edge AI to accelerate the search for life-saving treatments

Inherited blindness can now be cured with gene therapy

Inherited blindness can now be cured with gene therapy

BBC - 29-Apr-2021

A breakthrough gene therapy restores eyesight in patients with rare eye disease

$95M raised by Taysha for clinical trials of four new gene therapies

$95M raised by Taysha for clinical trials of four new gene therapies

FierceBiotech - 05-Aug-2020

Company has gathered support from investors to quickly lead therapies to clinic then market


Display all news

Novartis Creations

Luxturna (voretigene neparvovec)

Prescription gene therapy product for treatment of inherited retinal disease

People at Novartis

Troy Dale

Head Commercial - Strategic Partnerships Unit at Novartis and Board Member at Ochre Bio

Stephen Cleaver

Head of informatics systems at Novartis Institutes for Biomedical Research in Cambridge.

Vasant (Vas) Narasimhan

Chief Executive Officer of Novartis.

Topics mentioned on this page:
Laboratory Automation, Medical Technology